Since tumor-derived BRCA1 mutations eliminate E3-Ub ligase activity (Baer and Ludwig, 2002), it is clear that this activity of mammalian BRCA1–BARD1 is of critical functional importance. The gene discussed is BARD1; the disease is neoplasm.